Comment on Nauck et al. Effects of Liraglutide Compared With Placebo on Events of Acute Gallbladder or Biliary Disease in Patients With Type 2 Diabetes at High Risk for Cardiovascular Events in the LEADER Randomized Trial. Diabetes Care 2019;42:1912-1920

Marko Skelin, Dario Rahelić, Petar Skelin, Marko Lucijanic

Publikation: Bidrag til tidsskriftLetterForskningpeer review

1 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftDiabetes Care. Supplement
Vol/bind43
Udgave nummer2
Sider (fra-til)e28-e29
ISSN0149-5992
DOI
StatusUdgivet - 1 feb. 2020

Citationsformater